Industry News
Merck's acquisition of Sigma-Aldrich is coming closer to fruition
The United States, Russia, Serbia, Ukraine, South Africa, Taiwan, Japan and now China and Europe have cleared the way for Merck's acquisition of Sigma-Aldrich. [ + ]
New collaboration boosts Queensland's medical research
QUT to have access to specialist health and medical research laboratories and facilities in the QIMR Berghofer complex. [ + ]
Immune signals can predict cancer spread
Australian researchers have discovered that the key to effective breast cancer treatment may lie in predicting the path the cancer plans to take. [ + ]
Repurposing PPS
Paradigm Biopharmaceuticals is raising funds to develop PPS (pentosan polysulphate sodium) as a superior treatment for BME (bone marrow oedema) and allergic rhinitis. [ + ]
UniQuest and Janssen agreement focuses on immune system
A new research and development deal is hoped will realise new treatments for ankylosing spondylitis psoriasis and inflammatory bowel disease.
[ + ]European Inventor Award goes to Gardasil creators
The Queensland-based inventors of the Gardasil HPV vaccine have won the Popular Prize category of the 2015 European Inventor Award — a prestigious annual award that acknowledges inventors who have made major contributions towards social, technological and economic progress. [ + ]
Genetic Technologies appoints executive director
Molecular diagnostics company Genetic Technologies (ASX:GTG) has announced the casual appointment of Eutillio Buccilli as its new executive director. [ + ]
Free webinar on pluripotent stem cells
Lonza has announced that it is holding a free webinar, titled 'Pluripotent Stem Cells - From Research to Therapy', on 17 June. The webinar is aimed at helping researchers streamline pluripotent stem cells (PSC) workflow through various stages of research and development. [ + ]
The cause of neurodegenerative disorders takes shape
How can one protein's aggregates be the cause of several neurodegenerative disorders? Neurobiologists have discovered that the shape of these aggregates - 'cylinders' or 'ribbons' - determines whether a patient develops Parkinson's disease or multiple system atrophy, respectively. [ + ]
Injectable electronics could be the future of neuroscience
An international team of researchers, led by Harvard University Professor Charles Lieber, has developed a method for fabricating nanoscale electronic scaffolds that can be injected via syringe. [ + ]
Australian clinical scientist honoured in Copenhagen
The European Society of Clinical Microbiology and Infectious Diseases has announced University of Queensland Professor Jason Roberts as one of three winners of its 2015 Young Investigator Awards. [ + ]
IND reactivated for Prescient breast cancer drug
The US FDA has reactivated the Investigational New Drug (IND) for the novel drug candidate PTX-100 (formerly known as GGTI-2418) in a phase Ib trial for the treatment of metastatic breast cancer. [ + ]
Phosphagenics appoints consultant for promoting drug delivery tech
Phosphagenics (ASX:POH) has engaged the services of Dr Steve Meller to assist the company in partnering its TPM (Targeted Penetration Matrix) drug delivery technology with large companies selling into the mass market. [ + ]
Clinical Network Services is Australia's favourite CRO
Clinical Network Services (CNS), an integrated service group focused on clinical product development, has been announced as Australia's favourite CRO for 2015 by ARCS Australia. [ + ]
The search for Australia's next Chief Scientist
The Australian Government has begun the process to select Australia's next Chief Scientist, in preparation for the conclusion of Professor Ian Chubb's tenure at the end of the year. [ + ]
